Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by a nonspecific site interaction mechanism
- 31 May 1992
- journal article
- Published by Elsevier in Biophysical Journal
- Vol. 61 (5) , 1244-1255
- https://doi.org/10.1016/s0006-3495(92)81933-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- New approaches to drug design and delivery based on drug-membrane interactions.1991
- Partitioning and location of Bay K 8644, 1,4-dihydropyridine calcium channel agonist, in model and biological membranesBiophysical Journal, 1989
- Structure and location of amiodarone in a membrane bilayer as determined by molecular mechanics and quantitative x-ray diffractionBiophysical Journal, 1988
- Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayersBiophysical Journal, 1987
- Cellular effects of cannabinoids.1986
- Structural Analysis of Drug Molecules in Biological MembranesBiophysical Journal, 1986
- Rates of membrane-associated reactions: reduction of dimensionality revisited.The Journal of cell biology, 1986
- Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubulesBiophysical Journal, 1985
- KINETICS OF BINDING OF MEMBRANE-ACTIVE DRUGS TO RECEPTOR-SITES - DIFFUSION-LIMITED RATES FOR A MEMBRANE BILAYER APPROACH OF 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL ANTAGONISTS TO THEIR ACTIVE-SITE1985
- Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.The Journal of general physiology, 1977